VANESSA JOHNSON: Open Payments
NPI 1245474386 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,601 in 151 payments from 20 companies in 2025. Trend: 2023 $1,937 · 2024 $2,283 · 2025 $2,601
Food & beverage: $2,601
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 31 | $494 |
| ABBVIE INC. | 18 | $327 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $230 |
| E.R. Squibb & Sons, L.L.C. | 17 | $230 |
| UCB, Inc. | 13 | $224 |
| Arcutis Biotherapeutics, Inc. | 17 | $222 |
| Lilly USA, LLC | 8 | $139 |
| Amgen Inc. | 6 | $120 |
| PFIZER INC. | 1 | $114 |
| Incyte Corporation | 5 | $105 |
Products named: NEMLUVIO, Sotyktu, Bimzelx, RINVOQ, SKYRIZI, TALTZ, ILUMYA, OTEZLA.
Industry payments across MO — which companies pay providers there.
